CU24749B1 - Método para preparar una forma cristalina de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil) fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato - Google Patents
Método para preparar una forma cristalina de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil) fenil]-4h-quinazolin-4-il]acetato de sodio trihidratoInfo
- Publication number
- CU24749B1 CU24749B1 CU2022000049A CU20220049A CU24749B1 CU 24749 B1 CU24749 B1 CU 24749B1 CU 2022000049 A CU2022000049 A CU 2022000049A CU 20220049 A CU20220049 A CU 20220049A CU 24749 B1 CU24749 B1 CU 24749B1
- Authority
- CU
- Cuba
- Prior art keywords
- quinazolin
- piperazin
- methoxyphenyl
- trifluoromethyl
- fluoro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
<p>La presente invención se refiere a un método para preparar una forma cristalina de trihidrato de sodio del ácido 2-[(4S)-8-fluoro-2-[4-(3-metoxifenil) piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4H-quinazolin-4-il]acético de fórmula (I):</p> <p>ESPACIO PARA FÓRMULA</p> <p>que comprende las etapas de: proporcionar una solución de concentración entre de 0,3 M y 0,7 M de ácido 2-[(4S)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4H- quinazolin-4-il]acético en una mezcla de un acetato de alquilo (C1-C6): dialquil (C1-C6) ( 1:1 a 1:3) y en la que la temperatura de la solución está en el intervalo de 30 °C a 60 °C; añadir de 1,0 a 2,0 equivalentes molares de una solución acuosa de hidróxido de sodio basada en el contenido de ácido 2-[(4S)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4H-quinazolin-4-il]acético con respecto a la solución resultante de la etapa 1 para proporcionar una mezcla; agitar dicha mezcla resultante a una temperatura en el intervalo de 30 °C a 60 °C para obtener una suspensión que contiene un compuesto sólido; separar el compuesto sólido de la suspensión resultante; secar el compuesto sólido obtenido a una temperatura entre 30 °C y 60 °C para obtener 2-[(4S)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4H-quinazolin-4il]acetato de sodio trihidrato cristalino.</p>
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20159727 | 2020-02-27 | ||
| PCT/EP2021/055045 WO2021170874A1 (en) | 2020-02-27 | 2021-03-01 | A method of producing a crystalline form of sodium 2-[(4s)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4h-quinazolin-4-yl]acetate trihydrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CU20220049A7 CU20220049A7 (es) | 2023-04-10 |
| CU24749B1 true CU24749B1 (es) | 2025-05-05 |
Family
ID=69742722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2022000049A CU24749B1 (es) | 2020-02-27 | 2021-03-01 | Método para preparar una forma cristalina de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil) fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20230219899A1 (es) |
| EP (1) | EP4110470A1 (es) |
| JP (2) | JP7645276B2 (es) |
| KR (1) | KR102889550B1 (es) |
| CN (1) | CN115581118B (es) |
| AR (1) | AR121439A1 (es) |
| AU (1) | AU2021225363B2 (es) |
| BR (1) | BR112022016929A2 (es) |
| CA (1) | CA3169484A1 (es) |
| CL (1) | CL2022002291A1 (es) |
| CO (1) | CO2022012039A2 (es) |
| CU (1) | CU24749B1 (es) |
| EC (1) | ECSP22066680A (es) |
| IL (1) | IL295795A (es) |
| MX (1) | MX2022010441A (es) |
| PE (1) | PE20230515A1 (es) |
| PH (1) | PH12022552260A1 (es) |
| TW (1) | TWI870559B (es) |
| UA (1) | UA128999C2 (es) |
| UY (1) | UY39096A (es) |
| WO (1) | WO2021170874A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025133248A1 (en) | 2023-12-21 | 2025-06-26 | Aic246 Ag & Co. Kg | Diastereomeric aminoalcohol and aminoether salts of 2-[(4r,s)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl]acetic acid and their use for enantiomeric separation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10319612A1 (de) | 2003-05-02 | 2004-11-18 | Bayer Healthcare Ag | Substituierte Dihydrochinazoline |
| DE102012101659A1 (de) * | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Salze eines Dihydrochinazolinderivats |
-
2021
- 2021-02-26 UY UY0001039096A patent/UY39096A/es unknown
- 2021-02-26 AR ARP210100497A patent/AR121439A1/es unknown
- 2021-03-01 UA UAA202203502A patent/UA128999C2/uk unknown
- 2021-03-01 CA CA3169484A patent/CA3169484A1/en active Pending
- 2021-03-01 PE PE2022001822A patent/PE20230515A1/es unknown
- 2021-03-01 US US17/802,792 patent/US20230219899A1/en active Pending
- 2021-03-01 CU CU2022000049A patent/CU24749B1/es unknown
- 2021-03-01 KR KR1020227033588A patent/KR102889550B1/ko active Active
- 2021-03-01 WO PCT/EP2021/055045 patent/WO2021170874A1/en not_active Ceased
- 2021-03-01 EP EP21708227.0A patent/EP4110470A1/en active Pending
- 2021-03-01 BR BR112022016929A patent/BR112022016929A2/pt unknown
- 2021-03-01 MX MX2022010441A patent/MX2022010441A/es unknown
- 2021-03-01 IL IL295795A patent/IL295795A/en unknown
- 2021-03-01 PH PH1/2022/552260A patent/PH12022552260A1/en unknown
- 2021-03-01 JP JP2022551816A patent/JP7645276B2/ja active Active
- 2021-03-01 CN CN202180016769.0A patent/CN115581118B/zh active Active
- 2021-03-01 AU AU2021225363A patent/AU2021225363B2/en active Active
- 2021-03-02 TW TW110107368A patent/TWI870559B/zh active
-
2022
- 2022-08-22 CL CL2022002291A patent/CL2022002291A1/es unknown
- 2022-08-24 EC ECSENADI202266680A patent/ECSP22066680A/es unknown
- 2022-08-24 CO CONC2022/0012039A patent/CO2022012039A2/es unknown
-
2024
- 2024-10-23 JP JP2024186290A patent/JP2025016547A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2022010441A (es) | 2022-10-18 |
| KR20220148863A (ko) | 2022-11-07 |
| CA3169484A1 (en) | 2021-09-02 |
| JP7645276B2 (ja) | 2025-03-13 |
| US20230219899A1 (en) | 2023-07-13 |
| CN115581118A (zh) | 2023-01-06 |
| AR121439A1 (es) | 2022-06-08 |
| CN115581118B (zh) | 2025-01-28 |
| JP2023519813A (ja) | 2023-05-15 |
| IL295795A (en) | 2022-10-01 |
| WO2021170874A1 (en) | 2021-09-02 |
| ECSP22066680A (es) | 2022-12-30 |
| BR112022016929A2 (pt) | 2022-12-06 |
| CO2022012039A2 (es) | 2022-11-18 |
| TWI870559B (zh) | 2025-01-21 |
| TW202140453A (zh) | 2021-11-01 |
| AU2021225363A1 (en) | 2022-10-13 |
| AU2021225363B2 (en) | 2024-09-19 |
| CU20220049A7 (es) | 2023-04-10 |
| NZ792583A (en) | 2025-07-25 |
| CL2022002291A1 (es) | 2023-02-03 |
| JP2025016547A (ja) | 2025-02-04 |
| KR102889550B1 (ko) | 2025-11-24 |
| EP4110470A1 (en) | 2023-01-04 |
| PH12022552260A1 (en) | 2023-11-13 |
| UA128999C2 (uk) | 2024-12-18 |
| UY39096A (es) | 2021-09-30 |
| PE20230515A1 (es) | 2023-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2638147T3 (es) | Fosforamidatos de nucleósidos para producir ácidos nucleicos | |
| TWI570098B (zh) | 苯乙醯胺化合物的製造方法 | |
| BR112016006374B1 (pt) | Processo para fornecer um composto de fórmula (i) | |
| CU24749B1 (es) | Método para preparar una forma cristalina de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil) fenil]-4h-quinazolin-4-il]acetato de sodio trihidrato | |
| CN102442925B (zh) | 草酸酰胺酯及其盐的制备方法 | |
| ES2546059T3 (es) | Procedimiento para la preparación de 2,4-dioxotetrahidrofurano-3-carboxilatos | |
| RU2018114512A (ru) | Способ получения соединений индолина и новая соль индолина | |
| PE20090824A1 (es) | Proceso para la preparacion de trifluoralquil-fenil sulfonamidas y de sulfonamidas heterociclicas | |
| Boyd et al. | Sulfonic Acid Esters as Alkylating Agents: Formation of 2-Oxazolines1 | |
| CN106748724A (zh) | 一种以丙二酸酯为原料制备格尔伯特酸的方法 | |
| RU2010120061A (ru) | Способ получения замещенных 4-нитро-5-(2-оксоэтил)фталонитрилов | |
| RU2012130404A (ru) | Способ получения гормонов щитовидной железы и их солей | |
| Eberly et al. | On the formation and reactions of the substituted thiazolidones. IV | |
| MX2022010709A (es) | Proceso para la preparacion de amidas y carboxilatos del acido 5-cloro-3-alquilsulfanilo-piridina-2-carboxilico. | |
| ES2380267T3 (es) | Procedimiento para preparar ésteres dialquílicos del ácido tiodiglicólico | |
| JP4502315B2 (ja) | マンデロニトリル誘導体の製造法 | |
| JP7576921B2 (ja) | Ｏ－置換ヒドロキシルアミン誘導体の製造方法 | |
| CN102617485A (zh) | 一种三甲氧基苄基氨基嘧啶的水溶性衍生物的制备方法 | |
| JP3920499B2 (ja) | アルカノールまたはアルカンスルホン酸鉛の製造方法 | |
| EA200800861A1 (ru) | Способ получения четвертичных аммониевых солей с кислотой | |
| CN101941929A (zh) | 一种制备2,2-二甲基半胱胺盐的方法 | |
| RU2558145C1 (ru) | Способ промышленного получения азотзамещенного амино-5,6,7,8-тетрагидронафтола | |
| JP4351888B2 (ja) | スルファモイルオキシ基またはスルフィナモイルオキシ基が置換された芳香族化合物と求核剤との反応による芳香族化合物誘導体の製造方法 | |
| ES2650806T3 (es) | Procedimiento para la preparación de bencilaminas disustituidas halogenadas, particularmente dialquilbencilaminas halogenadas | |
| RU2021113507A (ru) | Соединение сложного эфира карбоновой кислоты, способ его получения и ароматизирующая композиция |